Kim Monkhorst

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Cancers

Cancer immunology research

JCO precision oncology

Erasmus MC (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Erasmus MC

Netherlands

PHD :: Cel biology

Publications

J W Tijmen van der Wel, Mirjam C Boelens, Merel Jebbink, Sietske A Smulders, Klaar W Maas, Merel J A Luitse, Annette Compter, Robin P B Boltjes, Nik Sol, Kim Monkhorst, Daan van den Broek, Egbert F Smit, Adrianus Johannes de Langen, Dieta Brandsma
Osimertinib-induced DNA resistance mutations in cerebrospinal fluid of EGFR mutated NSCLC patients developing leptomeningeal metastases: ORA-LM study. Neuro-oncology (2024)
Joris van de Haar, Joanne M Mankor, Karlijn Hummelink, Kim Monkhorst, Egbert F Smit, Lodewyk F A Wessels, Edwin Cuppen, Joachim G J V Aerts, Emile E Voest
Combining Genomic Biomarkers to Guide Immunotherapy in Non-Small Cell Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (7) (2024)
Michael V Martin, Salvador Aguilar-Rosas, Katka Franke, Mark Pieterse, Jamie van Langelaar, Renee Rce Schreurs, Maarten F Bijlsma, Marc G H Besselink, Jan Koster, Hidde J Haisma, Mustafa Khasraw, David M Ashley, Stephen T Keir, Christian Hermann Ottensmeier, Emma V King, Joanne Verheij, Cynthia Waasdorp, Peter J M Valk, Sem A G Engels, Ellen Oostenbach, Jip T van Dinter, Damon A Hofman, Juk Yee Mok, Wim J E van Esch, Hanneke Wilmink, Kim Monkhorst, Henk M W Verheul, Dennis Poel, Thijo Jeroen N Hiltermann, Léon C L T van Kempen, Harry J M Groen, Joachim G J V Aerts, Sebastiaan van Heesch, Bob Löwenberg, Ronald Plasterk, Wigard P Kloosterman
The neo-open reading frame peptides that comprise the tumor framome are a rich source of neoantigens for cancer immunotherapy. Cancer immunology research (2024)
Michael V Martin, Salvador Aguilar-Rosas, Katka Franke, Mark Pieterse, Jamie van Langelaar, Renee Rce Schreurs, Maarten F Bijlsma, Marc G H Besselink, Jan Koster, Hidde J Haisma, Mustafa Khasraw, David M Ashley, Stephen T Keir, Christian Hermann Ottensmeier, Emma V King, Joanne Verheij, Cynthia Waasdorp, Peter J M Valk, Sem A G Engels, Ellen Oostenbach, Jip T van Dinter, Damon A Hofman, Juk Yee Mok, Wim J E van Esch, Hanneke Wilmink, Kim Monkhorst, Henk M W Verheul, Dennis Poel, Thijo Jeroen N Hiltermann, Léon C L T van Kempen, Harry J M Groen, Joachim G J V Aerts, Sebastiaan van Heesch, Bob Löwenberg, Ronald Plasterk, Wigard P Kloosterman
The Neo-Open Reading Frame Peptides That Comprise the Tumor Framome Are a Rich Source of Neoantigens for Cancer Immunotherapy. Cancer immunology research 12 (6) (2024)
Julianne Cynthia de Ruiter, Adrianus Johannes de Langen, Kim Monkhorst, Alexander Veenhof, Houke M Klomp, Jasper Smit, Egbert F Smit, Ronald A M Damhuis, Koen J Hartemink
Survival difference between patients with single versus multiple metastatic lymph nodes and the role of histology in pathological stage II-N1 non-small cell lung cancer. Acta chirurgica Belgica (2024)
Joris van de Haar, Joanne M Mankor, Karlijn Hummelink, Kim Monkhorst, Egbert F Smit, Lodewyk F A Wessels, Edwin Cuppen, Joachim G J V Aerts, Emile E Voest
Combining genomic biomarkers to guide immunotherapy in non-small cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Joseph C Murray, Lavanya Sivapalan, Karlijn Hummelink, Archana Balan, James Robert White, Noushin Niknafs, Lamia Rhymee, Gavin Pereira, Nisha Rao, Benny Weksler, Nathan Bahary, Jillian A Phallen, Alessandro Leal, David L Bartlett, Kristen A Marrone, Jarushka Naidoo, Akul Goel, Benjamin Levy, Samuel Rosner, Christine L Hann, Susan C Scott, Josephine Feliciano, Vincent K Lam, David S Ettinger, Qing Kay Li, Peter B Illei, Kim Monkhorst, Robert B Scharpf, Julie R Brahmer, Victor E Velculescu, Blair A Jobe, Patrick M Forde, Valsamo Anagnostou
Elucidating the heterogeneity of immunotherapy response and immune-related toxicities by longitudinal ctDNA and immune cell compartment tracking in lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Karlijn Hummelink, Renaud Tissier, Linda J W Bosch, Oscar Krijgsman, Michel van den Heuvel, Willemijn S M E Theelen, Diane Damotte, Francois Goldwasser, Karen Leroy, Egbert F Smit, Gerrit A Meijer, Daniela S Thommen, Kim Monkhorst
A dysfunctional T cell gene signature for predicting non-response to PD-1 blockade in non-small cell lung cancer that is suitable for routine clinical diagnostics. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Luuk J Schipper, Kim Monkhorst, Kris G Samsom, Linda J W Bosch, Petur Snaebjornsson, Hester van Boven, Paul Roepman, Lizet E van der Kolk, Winan J van Houdt, Winette T A van der Graaf, Gerrit A Meijer, Emile E Voest
Clinical Impact of Prospective Whole Genome Sequencing in Sarcoma Patients. Cancers 14 (2) (2022)
Simone N Koole, Daan C L Vessies, Milou M F Schuurbiers, Astrid Kramer, Robert D Schouten, Koen Degeling, Linda J W Bosch, Michel M van den Heuvel, Wim H van Harten, Daan van den Broek, Kim Monkhorst, Valesca P Retèl
Cell-Free DNA at Diagnosis for Stage IV Non-Small Cell Lung Cancer: Costs, Time to Diagnosis and Clinical Relevance. Cancers 14 (7) (2022)
Karlijn Hummelink, Vincent van den Noort, Mirte Muller, Robert D Schouten, Ferry Lalezari, Dennis Peters, Willemijn S M E Theelen, Viktor Hendrik Koelzer, Kirsten D Mertz, Alfred Zippelius, Michel van den Heuvel, Annegien Broeks, John B A G Haanen, Ton N M Schumacher, Gerrit A Meijer, Egbert F Smit, Kim Monkhorst, Daniela S Thommen
PD-1T TILs as a Predictive Biomarker for Clinical Benefit to PD-1 Blockade in Patients with Advanced NSCLC. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (22) (2022)
Robert D Schouten, Daan C L Vessies, Linda J W Bosch, Nicole P Barlo, Anne S R van Lindert, Saskia A G M Cillessen, Daan van den Broek, Michel van den Heuvel, Kim Monkhorst
Clinical Utility of Plasma-Based Comprehensive Molecular Profiling in Advanced Non-Small-Cell Lung Cancer. JCO precision oncology 5 (2021)
Pieter J M Joosten, Chris Dickhoff, Vincent van den Noort, Maarten Smeekens, Rachel C Numan, Houke M Klomp, Judi N A van Diessen, Jose S A Belderbos, Egbert F Smit, Kim Monkhorst, Jan W A Oosterhuis, Michel M van den Heuvel, Max Dahele, Koen J Hartemink
Importance of tumour volume and histology in trimodality treatment of patients with Stage IIIA non-small cell lung cancer-results from a retrospective analysis. Interactive cardiovascular and thoracic surgery (2021)
Kris G Samsom, Linda J W Bosch, Luuk J Schipper, Paul Roepman, Ewart de Bruijn, Louisa R Hoes, Immy Riethorst, Lieke Schoenmaker, Lizet E van der Kolk, Valesca P Retèl, Geert W J Frederix, Tineke E Buffart, Jacobus J M van der Hoeven, Emile E Voest, Edwin Cuppen, Kim Monkhorst, Gerrit A Meijer
Study protocol: Whole genome sequencing Implementation in standard Diagnostics for Every cancer patient (WIDE). BMC medical genomics 13 (1) (2020)
Mirte Muller, Karlijn Hummelink, Daniel P Hurkmans, Anna-Larissa N Niemeijer, Kim Monkhorst, Joanna Roder, Carlos Oliveira, Heinrich Roder, Joachim G Aerts, Egbert F Smit
A Serum Protein Classifier Identifying Patients with Advanced Non-Small Cell Lung Cancer Who Derive Clinical Benefit from Treatment with Immune Checkpoint Inhibitors. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (19) (2020)

Kim Monkhorst.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kim Monkhorst